Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. [electronic resource]
Producer: 20090319Description: 247-54 p. digitalISSN:- 0022-3956
- Adult
- Antidepressive Agents -- therapeutic use
- Brain-Derived Neurotrophic Factor -- blood
- Citalopram -- therapeutic use
- Cyclohexanols -- therapeutic use
- Depressive Disorder, Major -- blood
- Enzyme-Linked Immunosorbent Assay
- Female
- Humans
- Linear Models
- Male
- Middle Aged
- Psychiatric Status Rating Scales
- Sertraline -- therapeutic use
- Severity of Illness Index
- Treatment Outcome
- Venlafaxine Hydrochloride
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.